Foghorn Therapeutics (FHTX) Other Working Capital Changes (2019 - 2026)

Foghorn Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $91000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 108.51% year-over-year to $91000.0; the TTM figure through Mar 2026 stood at -$28.4 million (down 310.64% YoY), while the FY2025 annual figure was -$30.9 million, down 289.18% from the prior year.
• Other Working Capital Changes was $91000.0 for Q1 2026 at Foghorn Therapeutics, up from -$21.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $9.4 million in Q3 2024 to a low of -$27.8 million in Q3 2023.
• Historically, Other Working Capital Changes has averaged -$4.2 million across 5 years, with a median of -$2.1 million in 2024.
• Biggest YoY gain for Other Working Capital Changes was 654.76% in 2022; the steepest drop was 35536.36% in 2022.
• A 5-year view of Other Working Capital Changes shows it stood at $5.6 million in 2022, then tumbled by 202.65% to -$5.8 million in 2023, then climbed by 6.6% to -$5.4 million in 2024, then plunged by 295.32% to -$21.3 million in 2025, then jumped by 100.43% to $91000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $91000.0 (Q1 2026), -$21.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.